Survived (n = 59a) | Died (n = 25a) | P-value | ||
---|---|---|---|---|
Vaccination | ||||
BCG | 57/58 (98.3) | 24/24 (100) | 1.00 | |
OPV | 56/58 (96.6) | 23/24 (95.8) | 1.00 | |
DTP-HepB-Hib | 51/57 (89.5) | 23/24 (95.8) | 0.67 | |
PCV13 | 50/57 (87.7) | 20/24 (83.3) | 0.72 | |
MMR | 48/57 (84.2) | 15/24 (62.5) | 0.10 | |
YF | 44/57 (77.2) | 13/24 (54.2) | 0.06 | |
Healthcare before hospital admissionb | ||||
Heath center | 51 (87.9) | 23 (92.0) | 0.72 | |
Biomedicine consultation | 54 (91.5) | 22 (88.0) | 0.69 | |
Traditional healer consultation | 23 (39.0) | 11 (44.0) | 0.67 | |
Hospitalization | 23 (39.0) | 6/24 (25.0) | 0.23 | |
Treatments before hospital admissionb | ||||
Antibiotics | 18 (30.5) | 2 (8.0) | 0.03 | |
Anti-malarial drugs | 22 (37.2) | 8 (32.0) | 0.64 | |
Anti-epileptic drugs | 4 (6.8) | 0 (0.0) | 0.31 | |
Blood transfusions | 2 (3.4) | 0 (0.0) | 1.00 | |
Means of transport | ||||
Car | 9 (15.3) | 4 (16.0) | 1.00 | |
Motorcycle | 50 (84.8) | 21 (84.0) | 1.00 | |
Travel time, hours, mean (SD) | 1.05 (0.71) | 1.10 (0.57) | 0.39 | |
Duration of symptoms before admission, days, mean (SD) | 4.68 (2.24) | 4.72 (2.46) | 0.85 |